Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats

American Journal of Pathology

Volumn 167, Issue 5, 2005, Pages 1429-1442

  Wang, Mingyi ^a   Zhang, Jing ^a   Spinetti, Gaia ^a   Jiang, Li Qun ^a   Monticone, Robert ^a   Zhao, Di ^a   Cheng, Linda ^a   Krawczyk, Melissa ^a   Talan, Mark ^a   Pintus, Gianfranco ^a   Lakatta, Edward G ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; COLLAGEN; GELATINASE A; ILOMASTAT; LOSARTAN; MATRIX METALLOPROTEINASE INHIBITOR; PHENYLEPHRINE; TRANSFORMING GROWTH FACTOR BETA1;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY INTIMA PROLIFERATION; ARTICLE; BASEMENT MEMBRANE; CAROTID ARTERY; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXPOSURE; GENETIC TRANSCRIPTION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA TRANSLATION; VASCULAR SMOOTH MUSCLE;

EID: 27544463037     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61229-1     Document Type: Article

References (56)

1. Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation 2003, 107:139-146
2. Wang M, Lakatta EG: Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging. Hypertension 2002, 39:865-873
3. Orlandi A, Marcellini M, Spagnoli LG: Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 2000, 20:1123-1136
4. Wang M, Takagi G, Asai K, Resuello RG, Natividad FF, Vatner DE, Vatner SF, Lakatta EG: Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 2003, 41:1308-1316
5. Virmani R, Avolio AP, Mergner WJ, Robinowitz M, Herderick EE, Cornhill JF, Quo SY, Liu TH, Ou DY, O'Rourke M: Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol 1991, 139:1119-1129
6. Challah M, Nadaud S, Philippe M, Battle T, Soubrier F, Corman B, Michel JB: Circulating and cellular markers of endothelial dysfunction with aging in rats. Am J Physiol 1997, 273:H1941-H1948
7. Touyz RM, Endemann D, He G, Li JS, Schiffrin EL: Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 1999, 33:366-372
8. Akasu M, Urata H, Kinoshita A, Sasaguri M, Ideishi M, Arakawa K: Differences in tissue angiotensin II-forming pathways by species and organs in vitro. Hypertension 1998, 32:514-520
9. Benetos A, Huguet F, Albaladejo P, Brisac AM, Pappo M, Safar ME, Levy BI: Role of adrenergic tone in mechanical and functional properties of carotid artery during aging. Am J Physiol 1993, 265:H1132-H1138
10. Rudner XL, Berkowitz DE, Booth JV, Funk BL, Cozart KL, D'Amico EB, El-Moalem H, Page SO, Richardson CD, Winters B, Marucci L, Schwinn DA: Subtype specific regulation of human vascular alpha (1)-adrenergic receptors by vessel bed and age. Circulation 1999, 100:2336-2343
11. Goettsch W, Lattmann T, Amann K, Szibor M, Morawietz H, Munter K, Muller SP, Shaw S, Barton M: Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. Biochem Biophys Res Commun 2001, 280:908-913
12. Li Z, Froehlich J, Galis ZS, Lakatta EG: Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 1999, 33:116-123
13. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG, Crow MT: Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 1994, 75:41-54
14. Lundberg MS, Crow MT: Age-related changes in the signaling and function of vascular smooth muscle cells. Exp Gerontol 1999, 34:549-557
15. Williams B: Angiotensin II and the pathophysiology of cardiovascular remodeling. Am J Cardiol 2001, 87:10C-17C
16. Strawn WB, Ferrario CM: Mechanisms linking angiotensin II and atherogenesis. Curr Opin Lipidol 2002, 13:505-512
17. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL: Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996, 98:418-425
18. Girerd X, Mourad JJ, Copie X, Moulin C, Acar C, Safar M, Laurent S: Noninvasive detection of an increased vascular mass in untreated hypertensive patients. Am J Hypertens 1994, 7:1076-1084
19. Oh LY, Larsen PH, Krekoski CA, Edwards DR, Donovan F, Werb Z, Yong VW: Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 1999, 19:8464-8475
20. Scuteri A, Chen CH, Yin FC, Chih-Tai T, Spurgeon HA, Lakatta EG: Functional correlates of central arterial geometric phenotypes. Hypertension 2001, 38:1471-1475
21. Brogelli L, Parenti A, Ledda F: Inhibition of vascular smooth muscle cell growth by angiotensin type 2 receptor stimulation for in vitro organ culture model. J Cardiovasc Pharmacol 2002, 39:739-745
22. Pauly RR, Bilato C, Cheng L, Monticone R, Crow MT: Vascular smooth muscle cell cultures. Methods Cell Biol 1997, 52:133-154
23. Galis ZS, Suknova GK, Libby P: Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J 1995, 9:974-980
24. Yamamoto K, Morishita R, Tomita N, Shimozato T, Nakagami H, Kikuchi A, Aoki M, Higaki J, Kaneda Y, Ogihara T: Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease. Circulation 2000, 102:1308-1314
25. Henrion D, Kubis N, Levy BI: Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension 2001, 38:1150-1157
26. Seyedi N, Koyama M, Mackins CJ, Levi R: Ischemia promotes renin activation and angiotensin formation in sympathetic nerve terminals isolated from the human heart: contribution to carrier-mediated norepinephrine release. J Pharmacol Exp Ther 2002, 302:539-544
27. Wang TT, Wu XH, Zhang SL, Chan JS: Molecular mechanism(s) of action of norepinephrine on the expression of the angiotensinogen gene in opossum kidney cells. Kidney Int 1998, 54:785-795
28. Jonsson JR, Smid SD, Frewin DB, Head RJ: Angiotensin II-mediated facilitation of sympathetic neurotransmission in the spontaneously hypertensive rat is not associated with neuronal uptake of the peptide. J Cardiovasc Pharmacol 1993, 22:750-753
29. Haudenschild CC, Prescott MF, Chobanian AV: Aortic endothelial and subendothelial cells in experimental hypertension and aging. Hypertension 1981, 3:1148-1153
30. Haudenschild CC, Chobanian AV: Blood pressure lowering diminishes age-related changes in the rat aortic intima. Hypertension 1984, 6:162-168
31. Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y: Interaction of mRNAs for angiotensin I.I type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension 1998, 32:467-472
32. Chesler NC, Ku DN, Galis ZS: Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo. Am J Physiol 1999, 277:H2002-H2009
33. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M, Nagai T, Fukamizu A, Umemura S, Iiri T, Fujita T, Komuro I: Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 2004, 6:499-506
34. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG: Role of p47 (phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002, 40:511-515
35. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J: Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 2002, 82:S12-S22
36. Pawlowski JE, Taylor DS, Valentine M, Hail ME, Ferrer P, Kowala MC, Molloy CJ: Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo. J Clin Invest 1997, 100:639-648
37. Pastore L, Tessitore A, Martinotti S, Toniato E, Alesse E, Bravi MC, Ferri C, Desideri G, Gulino A, Santucci A: Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 1999, 100:1646-1652
38. Tham DM, Martin-McNulty B, Wang YX, Wilson DW, Vergona R, Sullivan ME, Dole W, Rutledge JC: Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol Genomics 2002, 11:21-30
39. Muller DN, Mervaala EM, Dechend R, Fiebeler A, Park JK, Schmidt F, Theuer J, Breu V, Mackman N, Luther T, Schneider W, Gulba D, Ganten D, Haller H, Luft FC: Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. Am J Pathol 2000, 157:111-122
40. Ishibashi M, Hiasa K, Zhao Q, Inoue S, Ohtani K, Kitamoto S, Tsuchihashi M, Sugaya T, Charo IF, Kura S, Tsuzuki T, Ishibashi T, Takeshita A, Egashira K: Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ Res 2004, 94:1203-1210
41. Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, Koller A, Kaley G: Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 2002, 90:1159-1166
42. van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palacios-Callender M, Erusalimsky JD, Quaschning T, Malinski T, Gygi D, Ullrich V, Luscher TF: Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 2000, 192:1731-1744
43. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G: Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol Genomics 2004, 12:21-30
44. Yan ZQ, Sirsjo A, Bochaton-Piallat ML, Gabbiani G, Hansson GK: Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation. Arterioscler Thromb Vasc Biol 1999, 19:2854-2862
45. Moon SK, Cha BY, Lee YC, Nam KS, Runge MS, Patterson C, Kim CH: Age-related changes in matrix metalloproteinase-9 regulation in cultured mouse aortic smooth muscle cells. Exp Gerontol 2004, 39:123-131
46. Spinetti G, Wang M, Monticone RE, Zhang J, Zhao D, Lakatta EG: Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function. Arterioscler Thromb Vasc Biol 2004, 24:1397-1402
47. Spinetti G, Wang MY, Monticone RE, Zhang J, Di Z, Lakatta EG: The chemokine, MCP-1, activates metalloproteinase-2 production: a novel mechanism for vascular smooth muscle cell invasion. Circulation 2003, 108:3299
48. Kambayashi Y, Bardhan S, Inagami T: Peptide growth factors markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1993, 194:478-482
49. Abe J, Deguchi J, Matsumoto T, Takuwa N, Noda M, Ohno M, Makuuchi M, Kurokawa K, Takuwa Y: Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening. Circulation 1997, 96:1906-1913
50. Kim S, Zhan Y, Kim S, Izumi Y, Yasumoto H, Yano M, Iwao H: In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension. Arterioscler Thromb Vasc Biol 2000, 20:2539-2545
51. Kelly DJ, Cox AJ, Gow RM, Zhang Y, Kemp BE, Gilbert RE: Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo. Hypertension 2004, 44:195-202
52. Sarzani R, Arnaldi G, Takasaki I, Brecher P, Chobanian AV: Effects of hypertension and aging on platelet-derived growth factor and platelet-derived growth factor receptor expression in rat aorta and heart. Hypertension 1991, 18:11193-11199
53. Kopp CW, Holzenbein T, Steiner S, Marculescu R, Bergmeister H, Seidinger D, Mosberger I, Kaun C, Cejna M, Horvat R, Wojta J, Maurer G, Binder BR, Breuss JM, Ecker RC, de Martin R, Minar E: Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity. Blood 2004, 103:1653-1661
54. Saito S, Frank GD, Motley ED, Dempsey PJ, Utsunomiya H, Inagami T, Eguchi S: Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation. Biochem Biophys Res Commun 2002, 294:1023-1029
55. Michel JB, Heudes D, Michel O, Poitevin P, Philippe M, Scalbert E, Corman B, Levy BI: Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol 1994, 267:R124-R135
56. Huang W, Alhenc Gelas F, Osborne-Pellegrjn MJ: Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat. Circ Res 1998, 82:879-890